Both authors: Division of Pediatric Critical Care Medicine, Duke University Medical Center, Durham, NC.

*See also p. 1010.

Dr. Rotta received personal fees from Breas US for consulting and participation in a clinical advisory board, and royalties from Elsevier for editorial work. Dr. Straube disclosed he holds a patent (US20230110567A1) assigned to Duke University related to intravascular oxygenation devices; he disclosed he is a founder and has an equity interest in VQ Biomedical, a company developing novel treatments for hypoxic respiratory failure; and receives grant funding from the Duke-Coulter Translational Partnership.